Skin Is Remarkable

Skin not only protects but provides valuable functions to every man, woman and child.  So remarkable is skin that SWITCH BIOTECH is committed to make it a science.

Knowledge And Expertise

SWITCH BIOTECH uses its broad knowledge and expertise of the molecular biology of the skin to develop drugs for various skin disorders.  By using proprietary technology, SWITCH can rapidly profile potential new and re-profile existing compounds for possible treatments for a variety of diseases.

Therapeutic areas of interest include Psoriasis, Atopic Dermatitis, Vitiligo, Androgenic Alopecia and other non-dermatologic areas.

By using functional genomics, SWITCH's goal is to identify key targets involved in skin diseases.  We have gained comprehensive knowledge about the molecular biology of skin and have developed novel approaches to the development of new drugs by validating targets, assays and compounds.


 

Unique Discovery Platform

The company applies its comprehensive functional genomics platform to discover and develop medicines and mechanism-based drugs that treat a variety of dermatological diseases and other therapeutic conditions.

Leading In Biotech Research

SWITCH BIOTECH is leading the way as a leader of biotech companies to specialize in dermatological related areas. 

SWITCH has developed one of the largest pools of knowledge and expertise concerning the molecular biology of the skin which in the future could treat various skin diseases.